SCM
LLY icon

Suvretta Capital Management’s Eli Lilly LLY Stock Holding History

Suvretta Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-39,100
Closed -$21M – 92
2023
Q3 		$21M Buy
+39,100
New +$20.1M 1.13% 28
2022
Q4 		– Sell
-35,200
Closed -$11.4M – 97
2022
Q3 		$11.4M Buy
+35,200
New +$11.2M 0.47% 47

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Suvretta Capital Management's LLY Position: Q4 2023 in Review

Suvretta Capital Management sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 39,100 shares — an estimated $21M sold.

Suvretta Capital Management first reported a position in LLY in Q3 2022 and held it in 2 quarters. The position peaked at $21M in Q3 2023. 3,273 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Suvretta Capital Management reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Suvretta Capital Management sold 39,100 Eli Lilly shares in Q4 2023, an estimated $21M.
  • Suvretta Capital Management first reported a position in Eli Lilly in Q3 2022 and held it in 2 quarters.
  • Suvretta Capital Management's Eli Lilly position peaked at $21M in Q3 2023.
  • 3,273 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Suvretta Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.